Helus Pharma

With 2 lead drug programs and a class-leading patent portfolio, @Helus_Pharma is pioneering a paradigm shift in mental health that empowers the healing process. Learn more: helus.com/intellectual-p…↩️

Participants in @Helus_Pharma's Phase 2 study receiving two 16 mg doses of HLP003 showed a 100% response rate and 71% remission from Major Depressive Disorder at 12 months. Learn more: helus.com/hlp003↩️

Last week, Helus Pharma began trading on @Nasdaq under the ticker $HELP. A big milestone made possible by an incredible team working to shift the mental health treatment paradigm and bring new therapeutic options to patients in need. Grateful for everyone who brought us here. 🚀🧠💙

Inspiring to see Helus Pharma up in lights on the @Nasdaq tower in @TimesSquareNYC this week as we ring in a new era of mental health innovation on the world's most innovative exchange.🔔🎆 Learn more: helus.com ↩️

Co-Founder & Executive Chairman Eric So and the Helus Pharma team ring the @Nasdaq opening bell. Learn more: helus.com | Nasdaq: $HELP

Helus Pharma rings the @Nasdaq opening bell and launches a new era in mental health innovation!

Join the @HelusPharma @Nasdaq bell ringing ceremony this morning! Watch here: nasdaq.com/marketsite/bel… $HELP

We are proud to begin trading on the @Nasdaq today as we advance our mission to pioneer a paradigm shift in mental health that empowers the healing process. Learn more: shorturl.at/CRnq1